Skip to main content
Caplight Logo









Oppilotech

Oppilotech

Private
LondonHealthcare & Life Scienceshttps://oppilotech.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$1.95M

Company Overview

Oppilotech is a biotechnology company that utilizes systems biology and machine learning platforms to build predictive computational models of cells for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

computational biologydrug discoverysystems biologyantibiotic resistancein silico drug discoverybacterial modelinganti-infective therapydigital biologytarget identificationai drug discoverywhole-cell modelingbiotech platformdrug target discoverycomputational modelingpharma r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oppilotech Comparables

Compare Oppilotech with similar companies based on industry and business-model similarity.

Oppilotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phare Bio
76%
Evariste
71%
Deep Origin
69%

Oppilotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantMay 1, 2020
GrantApr 1, 2019
AcceleratorJul 11, 2018
GrantJan 1, 2018
Grant
Jul 1, 2017

Key People

Founding team and executive leadership

Ajay Mistry

Founder CEO

Founding Team

Oppilotech Investors

Notable investors and investment history

Oppilotech investors
InvestorRounds
CARB-XGrant
Innovate UKGrant
Accelerate@BabrahamAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 2476% MoM, from 50 to 1.3K.

  • May 1, 2020

    $74K grant received from Innovate UK.

Oppilotech Filings

Explore SEC and related filing metadata, where available.

Oppilotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oppilotech's valuation, stock price, and market status.

Is Oppilotech a public or private company?

Oppilotech is a private company.

What is the current stock price of Oppilotech?

Oppilotech is a private company with no public stock price. No recent secondary market data is available.

How much is Oppilotech worth (valuation)?

Valuation information for Oppilotech is not publicly available.

Can I buy Oppilotech stock?

Oppilotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oppilotech's last funding round?

Oppilotech's most recent funding round was Grant on September 1, 2023.

Who are the main investors in Oppilotech?

Key investors in Oppilotech include CARB-X, Innovate UK, Accelerate@Babraham.

Will Oppilotech IPO soon?

No public IPO plans have been announced for Oppilotech.

How can I track Oppilotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oppilotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2014
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?